Relais reported Q4 adjusted EBITA of EUR 10.6m, 10% above LSEG Data & Analytics consensus.
Redeye’s initial take on Stille’s year-end report is positive.
Redeye comments on Doro´s fourth quarter of the year.
Redeye comments on Embracer’s Q3-results which were in line with the preannounced results.
Q4 EBIT SEK 437m (vs. ABSCe 495m) No big surprises, Centennial Flats main Q4 contributor Financial t...
VibroSense redovisade en nettoomsättning om 0,46 MSEK (0,57) i kvartalet, vilket var en minskning me...
CapMan’s underlying performance in Q4 was solid and slightly above our estimates.
Minor estimate revisions To achieve run-rate output in new factories in H2'27e '25e EV/EBIT 7-8x Ba...
Redeye comments on G5’s Q4-results which saw revenue in line with our forecast while results where s...
Atria reported Q4 adjusted EBIT of EUR 13.2m, 19% (EUR 3.
Redeye provides an update following Neola Medical’s Q4 2024 report.
Taaleri delivered a solid Q4, with continued earnings growth of 6% y/y and EBIT of EUR 9.
Redeye retains its positive view of Vertiseit following a solid Q4 that largely matches our expectat...
Small beat in Q4 and news of CEO leaving Adj. EBITDA up 2.
On February 12th, Eevia Health Plc (publ) (“Eevia”) announced that the Company has signed a term she...
Både försäljning och rörelseresultat överträffade våra förväntningar för fjärde kvartalet.
Alisa Bank reports its H2 results on February 14th.
Marimekko reports its Q4/24 figures on 19th of February.
Q4 report Wednesday, 19 February at 08:30 CET '24e EBITA up 4% 25-9x EBITA in '24e-'26e, 5-18% FCF y...
Sales +7% and EBIT +34% vs. ABGSCe Organic growth of +13%, above ABGSCe +6% Limited but positive con...
